4-Phenylbutyric Acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Flunisolide.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Flunisolide.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Flunisolide.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flunisolide.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Flunisolide.
Aldesleukin
Flunisolide may decrease the antineoplastic activities of Aldesleukin.
Advertisement
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Flunisolide.
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Flunisolide.
Aluminum
The bioavailability of Flunisolide can be decreased when combined with Aluminium.
Advertisement
Aluminum Hydroxide
The bioavailability of Flunisolide can be decreased when combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The bioavailability of Flunisolide can be decreased when combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The bioavailability of Flunisolide can be decreased when combined with Almasilate.
Ambenonium
The risk or severity of adverse effects can be increased when Flunisolide is combined with Ambenonium.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Flunisolide.
Amiodarone
The metabolism of Flunisolide can be decreased when combined with Amiodarone.
Amoxapine
The therapeutic efficacy of Flunisolide can be decreased when used in combination with Amoxapine.
Amphotericin B
Flunisolide may increase the hypokalemic activities of Amphotericin B.
amphotericin B liposomal
Flunisolide may increase the hypokalemic activities of Amphotericin B.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Flunisolide is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Flunisolide.
Apalutamide
The serum concentration of Flunisolide can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Flunisolide.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Flunisolide.
Aprepitant
The serum concentration of Flunisolide can be increased when it is combined with Aprepitant.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flunisolide.
Atazanavir
The metabolism of Flunisolide can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Flunisolide can be decreased when combined with Atomoxetine.
Atracurium Besylate
Atracurium besylate may increase the adverse neuromuscular activities of Flunisolide.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Flunisolide.
Azosemide
Flunisolide may increase the hypokalemic activities of Azosemide.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Flunisolide.
BCG Vaccine
The risk or severity of adverse effects can be increased when Flunisolide is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Flunisolide is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Flunisolide is combined with Bacillus calmette-guerin substrain tice live antigen.
Bendroflumethiazide
Flunisolide may increase the hypokalemic activities of Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Flunisolide.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Flunisolide.
Bismuth Subcitrate
The bioavailability of Flunisolide can be decreased when combined with Bismuth Subcitrate.
Boceprevir
The metabolism of Flunisolide can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Flunisolide can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Flunisolide can be decreased when it is combined with Bosentan.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Flunisolide.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Flunisolide.
Bumetanide
Flunisolide may increase the hypokalemic activities of Bumetanide.
Calcitriol
The therapeutic efficacy of Calcitriol can be decreased when used in combination with Flunisolide.
Calcium Carbonate
The bioavailability of Flunisolide can be decreased when combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The bioavailability of Flunisolide can be decreased when combined with Calcium Carbonate.
Capromab Pendetide
Flunisolide may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Carbamazepine
The metabolism of Flunisolide can be increased when combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Flunisolide.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Flunisolide.
Ceritinib
The serum concentration of Flunisolide can be increased when it is combined with Ceritinib.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Flunisolide.
Chlorothiazide
Flunisolide may increase the hypokalemic activities of Chlorothiazide.
Chlorotrianisene
The serum concentration of Flunisolide can be increased when it is combined with Chlorotrianisene.
Chlorthalidone
Flunisolide may increase the hypokalemic activities of Chlorthalidone.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Flunisolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Flunisolide.
Cinoxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Cinoxacin.
Clarithromycin
The metabolism of Flunisolide can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Flunisolide can be decreased when combined with Clemastine.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Flunisolide.
Clotrimazole
The metabolism of Flunisolide can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Flunisolide can be decreased when combined with Cobicistat.
Colesevelam
Colesevelam can cause a decrease in the absorption of Flunisolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Flunisolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Flunisolide.
Corticorelin Ovine
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Flunisolide.
Corticorelin Ovine Triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Flunisolide.
Crizotinib
The metabolism of Flunisolide can be decreased when combined with Crizotinib.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Flunisolide.
Cyclopenthiazide
Flunisolide may increase the hypokalemic activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Flunisolide can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Flunisolide can be decreased when it is combined with Dabrafenib.
Danazol
Flunisolide may increase the fluid retaining activities of Danazol.
Darunavir
The metabolism of Flunisolide can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Flunisolide can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Flunisolide can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Flunisolide can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Flunisolide can be decreased when combined with Delavirdine.
Demecarium
The risk or severity of adverse effects can be increased when Flunisolide is combined with Demecarium.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flunisolide.
Dienestrol
The serum concentration of Flunisolide can be increased when it is combined with Dienestrol.
Diethylstilbestrol
The serum concentration of Flunisolide can be increased when it is combined with Diethylstilbestrol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Flunisolide.
Dihydroergotamine
The metabolism of Flunisolide can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Flunisolide can be decreased when combined with Diltiazem.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Flunisolide.
Distigmine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Distigmine.
Donepezil
The risk or severity of adverse effects can be increased when Flunisolide is combined with Donepezil.
Doxycycline
The metabolism of Flunisolide can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Flunisolide can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Flunisolide can be decreased when combined with Dronedarone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Flunisolide.
Echothiophate
The risk or severity of adverse effects can be increased when Flunisolide is combined with Echothiophate.
Edrophonium
The risk or severity of adverse effects can be increased when Flunisolide is combined with Edrophonium.
Enoxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Enoxacin.
Enzalutamide
The serum concentration of Flunisolide can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The serum concentration of Flunisolide can be increased when it is combined with Equol.
Erythromycin
The metabolism of Flunisolide can be decreased when combined with Erythromycin.
Estradiol
The serum concentration of Flunisolide can be increased when it is combined with Estradiol.
Estradiol acetate
The serum concentration of Flunisolide can be increased when it is combined with Estradiol acetate.
Estradiol Cypionate
The serum concentration of Flunisolide can be increased when it is combined with Estradiol cypionate.
Estradiol Valerate
The serum concentration of Flunisolide can be increased when it is combined with Estradiol valerate.
Estriol
The serum concentration of Flunisolide can be increased when it is combined with Estriol.
Estrogens, Conjugated (USP)
The serum concentration of Flunisolide can be increased when it is combined with Conjugated estrogens.
Estrogens, Esterified (USP)
The serum concentration of Flunisolide can be increased when it is combined with Estrogens, esterified.
Estrone
The serum concentration of Flunisolide can be increased when it is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Flunisolide.
Ethacrynate
Flunisolide may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Flunisolide may increase the hypokalemic activities of Etacrynic acid.
Ethinyl Estradiol
The serum concentration of Flunisolide can be increased when it is combined with Ethinyl Estradiol.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Flunisolide.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Flunisolide.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Flunisolide.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Flunisolide.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Flunisolide.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Flunisolide.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Flunisolide.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Flunisolide.
Fleroxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Flunisolide.
Fluconazole
The metabolism of Flunisolide can be decreased when combined with Fluconazole.
Flumequine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Flumequine.
Fluoxymesterone
Flunisolide may increase the fluid retaining activities of Fluoxymesterone.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Flunisolide.
Fluvoxamine
The metabolism of Flunisolide can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Flunisolide can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Flunisolide can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Flunisolide can be increased when combined with Fosphenytoin.
Furosemide
Flunisolide may increase the hypokalemic activities of Furosemide.
Fusidate
The serum concentration of Flunisolide can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Flunisolide can be increased when it is combined with Fusidic Acid.
Galantamine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Gallamine Triethiodide.
Gatifloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of adverse effects can be increased when Flunisolide is combined with Gatifloxacin.
Gemifloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Gemifloxacin.
Gemifloxacin Mesylate
The risk or severity of adverse effects can be increased when Flunisolide is combined with Gemifloxacin.
Genistein
The serum concentration of Flunisolide can be increased when it is combined with Genistein.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Flunisolide is combined with Ginkgo biloba.
Glycerol Phenylbutyrate
The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Flunisolide.
Grepafloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Grepafloxacin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Flunisolide is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Hepatitis B Vaccine (Recombinant).
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunisolide.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunisolide.
Hydrochlorothiazide
Flunisolide may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Flunisolide may increase the hypokalemic activities of Hydroflumethiazide.
Hydrotalcite
The bioavailability of Flunisolide can be decreased when combined with Hydrotalcite.
Hypoxis hemerocallidea root extract
The serum concentration of Flunisolide can be decreased when it is combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flunisolide.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Flunisolide.
Idelalisib
The metabolism of Flunisolide can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Flunisolide can be decreased when combined with Imatinib.
Indacaterol
Indacaterol may increase the hypokalemic activities of Flunisolide.
Indapamide
Flunisolide may increase the hypokalemic activities of Indapamide.
Indinavir
The metabolism of Flunisolide can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Flunisolide can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Flunisolide.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Flunisolide.
Isavuconazole
The serum concentration of Flunisolide can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Flunisolide can be decreased when combined with Isavuconazonium.
Isoflurophate
The risk or severity of adverse effects can be increased when Flunisolide is combined with Isoflurophate.
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Flunisolide.
Isradipine
The metabolism of Flunisolide can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Flunisolide can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Flunisolide can be increased when it is combined with Ivacaftor.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Flunisolide.
Ketoconazole
The metabolism of Flunisolide can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Flunisolide.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Flunisolide.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Flunisolide.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Flunisolide.
Levofloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of adverse effects can be increased when Flunisolide is combined with Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Flunisolide.
Lopinavir
The metabolism of Flunisolide can be decreased when combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Flunisolide.
Lovastatin
The metabolism of Flunisolide can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Flunisolide.
Luliconazole
The serum concentration of Flunisolide can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Flunisolide can be increased when combined with Lumacaftor.
Magaldrate
The bioavailability of Flunisolide can be decreased when combined with Magaldrate.
Magnesium Hydroxide
The bioavailability of Flunisolide can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide
The bioavailability of Flunisolide can be decreased when combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Flunisolide.
Magnesium Trisilicate
The bioavailability of Flunisolide can be decreased when combined with Magnesium Trisilicate.
Malathion
The risk or severity of adverse effects can be increased when Flunisolide is combined with Malathion.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Flunisolide.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Flunisolide.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Flunisolide.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Flunisolide.
Mefloquine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Mefloquine.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Flunisolide.
Memantine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Memantine.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Flunisolide.
Mesterolone
Flunisolide may increase the fluid retaining activities of Mesterolone.
Mestranol
The serum concentration of Flunisolide can be increased when it is combined with Mestranol.
Methyclothiazide
Flunisolide may increase the hypokalemic activities of Methyclothiazide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Flunisolide.
Methyltestosterone
Flunisolide may increase the fluid retaining activities of Methyltestosterone.
Metoclopramide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Metoclopramide.
Metolazone
Flunisolide may increase the hypokalemic activities of Metolazone.
Mifepristone
The therapeutic efficacy of Flunisolide can be decreased when used in combination with Mifepristone.
Minaprine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Minaprine.
Mitotane
The serum concentration of Flunisolide can be decreased when it is combined with Mitotane.
Mivacurium
Mivacurium may increase the adverse neuromuscular activities of Flunisolide.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Flunisolide.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Flunisolide.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Flunisolide.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Flunisolide.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Flunisolide.
Nalidixic Acid
The risk or severity of adverse effects can be increased when Flunisolide is combined with Nalidixic Acid.
Nandrolone
Flunisolide may increase the fluid retaining activities of Nandrolone.
Nandrolone Decanoate
Flunisolide may increase the fluid retaining activities of Nandrolone decanoate.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Flunisolide.
Nefazodone
The metabolism of Flunisolide can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Flunisolide can be decreased when combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Neostigmine.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Flunisolide.
Netupitant
The serum concentration of Flunisolide can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Flunisolide can be increased when combined with Nevirapine.
Nicorandil
The risk or severity of adverse effects can be increased when Flunisolide is combined with Nicorandil.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Flunisolide.
Nilotinib
The metabolism of Flunisolide can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Flunisolide.
Norfloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Norfloxacin.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when Flunisolide is combined with 1,10-Phenanthroline.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Flunisolide.
Olaparib
The metabolism of Flunisolide can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Flunisolide.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Flunisolide.
Osimertinib
The serum concentration of Flunisolide can be increased when it is combined with Osimertinib.
Oxandrolone
Flunisolide may increase the fluid retaining activities of Oxandrolone.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Flunisolide.
Oxymetholone
Flunisolide may increase the fluid retaining activities of Oxymetholone.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Flunisolide.
Palbociclib
The serum concentration of Flunisolide can be increased when it is combined with Palbociclib.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Flunisolide.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Flunisolide.
Pefloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Pefloxacin.
Pentobarbital
The metabolism of Flunisolide can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Flunisolide can be increased when combined with Phenobarbital.
Phenylacetic Acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Flunisolide.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Flunisolide.
Phenylbutyrate
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Flunisolide.
Phenytoin
The metabolism of Flunisolide can be increased when combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Physostigmine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Flunisolide.
Piretanide
Flunisolide may increase the hypokalemic activities of Piretanide.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Flunisolide.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Flunisolide.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Flunisolide.
Polyestradiol Phosphate
The serum concentration of Flunisolide can be increased when it is combined with Polyestradiol phosphate.
Polythiazide
Flunisolide may increase the hypokalemic activities of Polythiazide.
Posaconazole
The metabolism of Flunisolide can be decreased when combined with Posaconazole.
Primidone
The metabolism of Flunisolide can be increased when combined with Primidone.
Promestriene
The serum concentration of Flunisolide can be increased when it is combined with Promestriene.
Pyridostigmine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Pyridostigmine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Pyridostigmine.
Quinestrol
The serum concentration of Flunisolide can be increased when it is combined with Quinestrol.
Quinethazone
Flunisolide may increase the hypokalemic activities of Quinethazone.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Flunisolide is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rabies virus inactivated antigen, A.
Ranolazine
The metabolism of Flunisolide can be decreased when combined with Ranolazine.
Rapacuronium
Rapacuronium may increase the adverse neuromuscular activities of Flunisolide.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Flunisolide.
Rifabutin
The metabolism of Flunisolide can be increased when combined with Rifabutin.
Rifampin
The metabolism of Flunisolide can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Flunisolide can be increased when combined with Rifapentine.
Rivastigmine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rivastigmine.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Flunisolide.
Rosoxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rosoxacin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Flunisolide is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Flunisolide can be decreased when combined with Rucaparib.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Flunisolide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Flunisolide.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Flunisolide is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Flunisolide.
Saquinavir
The metabolism of Flunisolide can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Flunisolide can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Flunisolide can be decreased when used in combination with Sarilumab.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Flunisolide.
Sildenafil
The metabolism of Flunisolide can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Flunisolide can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Flunisolide can be increased when it is combined with Simeprevir.
Sodium Bicarbonate
The bioavailability of Flunisolide can be decreased when combined with Sodium bicarbonate.
Sparfloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Flunisolide can be decreased when it is combined with St. John's Wort.
Stanozolol
Flunisolide may increase the fluid retaining activities of Stanozolol.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Flunisolide.
Sulfisoxazole
The metabolism of Flunisolide can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Flunisolide.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Flunisolide.
synthetic conjugated estrogens, A
The serum concentration of Flunisolide can be increased when it is combined with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The serum concentration of Flunisolide can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Tacrine.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Flunisolide.
Telithromycin
The metabolism of Flunisolide can be decreased when combined with Telithromycin.
Temafloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Temafloxacin.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Flunisolide.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Flunisolide.
Testosterone
Flunisolide may increase the fluid retaining activities of Testosterone.
Testosterone Cypionate
Flunisolide may increase the fluid retaining activities of Testosterone cypionate.
Testosterone Enanthate
Flunisolide may increase the fluid retaining activities of Testosterone enanthate.
Testosterone Propionate
Flunisolide may increase the fluid retaining activities of Testosterone propionate.
Testosterone Undecanoate
Flunisolide may increase the fluid retaining activities of Testosterone undecanoate.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Flunisolide is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Flunisolide.
Tibolone
The serum concentration of Flunisolide can be increased when it is combined with Tibolone.
Ticlopidine
The metabolism of Flunisolide can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Flunisolide can be decreased when it is combined with Tocilizumab.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Flunisolide.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Flunisolide.
Torsemide
Flunisolide may increase the hypokalemic activities of Torasemide.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Flunisolide.
Trichlormethiazide
Flunisolide may increase the hypokalemic activities of Trichlormethiazide.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Flunisolide.
Tromethamine
The bioavailability of Flunisolide can be decreased when combined with Tromethamine.
Trovafloxacin
The risk or severity of adverse effects can be increased when Flunisolide is combined with Trovafloxacin.
Tubocurarine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Tubocurarine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Flunisolide is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Flunisolide is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Flunisolide.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Flunisolide is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Flunisolide can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Flunisolide can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Flunisolide can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Flunisolide can be decreased when combined with Voriconazole.
Warfarin
Flunisolide may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Flunisolide is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Flunisolide is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Flunisolide.
Ziprasidone
The metabolism of Flunisolide can be decreased when combined with Ziprasidone.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Flunisolide.
